SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?


To: aknahow who wrote (349)1/28/1999 8:48:00 AM
From: LLCF  Respond to of 712
 
Sales were not running at $700,000 the last week of the year. They must have been much higher, giving an average of $700,000 per week for the last quarter. >

It sounds like this thing could take CORR at least to $0 burn???

DAK



To: aknahow who wrote (349)1/28/1999 9:02:00 AM
From: LLCF  Read Replies (1) | Respond to of 712
 
Just read the earnings statement by CNTO..."Reopro":

biz.yahoo.com

This on the face of it looks TERRIBLE for CORR, but perhaps its so new it hasn't had the chance to go head to head with Reopro?

Be ready for a buying opportunity on this news today IMO, :( .

DAK